Thursday, October 18, 2018 7:22:35 PM
The class action shareholder plaintiff lawsuits will take all the D&O insurance coverage and still likely have a hefty judgment outstanding against the MGTI assets. Also, as the existing SEC case against Honig and Ladd proceeds through discovery, it is very likely that the company itself will be added as a defendant. It highly likely that additional management/directors have committed malfeasance and you can bett that Honig and Ladd will try to deflect blame by pointing at others on the Bored and in mismangement - prolly including Bath Salts Johnny. Once the SEC has this basis to obtain warrants for the trading accounts and bank accounts of the other directors and (mis)management, like Bath Salts Johnny, the SEC case will expand adding them and the corp as additional defendants or at minimum relief defendants.
A LOTT of munny was lost in the MGTI scam, and the D&O insurance (if any) has a low coverage cap that won't come near to covering the judgements against the management and directors, let alone the corporation itself. This was nott your typical pennyscam - MGTI lost a TON of market cap - and that's all DAMAGES for the plaintiffs to claim.
MGTI will gradually, over the course of the various lawsuits, drift down to the true value of the common stock- ZERO.
This turd is finished like SPNG - way too much munny was lost by investors.
Recent MGTI News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 09:30:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 06:21:10 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/29/2023 05:15:26 AM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 12/22/2023 09:30:32 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 12/22/2023 09:30:32 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 12/22/2023 09:30:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/20/2023 01:30:39 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/13/2023 04:29:30 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 05:27:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/27/2023 09:15:13 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM